The Menier Chocolate Factory and principal sponsor Pinsent Masons announce Golden Tickets

27 Aug 2014 | 01:07 pm |

International law firm Pinsent Masons, in conjunction with the Menier Chocolate Factory, is delighted to announce the launch of a brand new subsidised theatre tickets scheme, targeting young theatregoers aged 16-21.

The scheme will support three productions a year, and will offer a minimum of 200 subsidised tickets per production, bringing the ticket price to only £10. Making theatre accessible to a young audience is one of the key aims of the new sponsorship initiative launched earlier this year between Pinsent Masons and the Menier Chocolate Factory. By offering affordable tickets to a younger audience, the scheme enables young minds to discover theatre they may never have been able to see otherwise, offering new experiences and vital arts influence.

The Golden Tickets scheme launches on Tuesday 26th August with £10 tickets available for performances of the Chocolate Factory’s forthcoming comedy Fully Committed (3rd September – 15th November).

Customers wishing to buy subsidised tickets should visit www.menierchocolatefactory.com to register with the scheme.

 

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts